In-Depth: With COVID therapies scarce, studies suggest a common pill has promise

Rather than leave high-risk patients untreated in the early stages of infection, some doctors are turning to a widely available drug called fluvoxamine.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting